Ormdl3 regulation of specific ceramides is dispensable for β-cell function and glucose homeostasis under obesogenic conditions.
Ormdl3 regulation of specific ceramides is dispensable for β-cell function and glucose homeostasis under obesogenic conditions.
复制标题
特定神经酰胺的 Ormdl3 调节对于肥胖条件下的 β 细胞功能和葡萄糖稳态是可有可无的。
DOI:
10.1101/2023.02.11.528130
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Engin,Feyza
中科院分区:
文献类型:
--
作者:
Hurley,LiamD;Lee,Hugo;Wade,Gina;Simcox,Judith;Engin,Feyza
Chronic elevation of sphingolipids contributes to β-cell failure. ORMDL3 has been identified as a key regulator of sphingolipid homeostasis, however, its function in pancreatic β-cell pathophysiology remains unclear. Here, we generated a mouse model lacking Ormdl3 within pancreatic β-cells (Ormdl3β−/−). We show that loss of β-cell Ormdl3 does not alter glucose tolerance, insulin sensitivity, insulin secretion, islet morphology, or cellular ceramide levels on standard chow diet. When challenged with a high fat diet, while Ormdl3β−/− mice did not exhibit any alteration in metabolic parameters or islet architecture, lipidomics analysis revealed significantly higher levels of very long chain ceramides in their islets. Taken together, our results reveal that loss of Ormdl3 alone is not sufficient to impinge upon β-cell function or whole-body glucose and insulin homeostasis, but loss of Ormdl3 does alter specific sphingolipid levels.